JP2002501021A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002501021A5 JP2002501021A5 JP2000528283A JP2000528283A JP2002501021A5 JP 2002501021 A5 JP2002501021 A5 JP 2002501021A5 JP 2000528283 A JP2000528283 A JP 2000528283A JP 2000528283 A JP2000528283 A JP 2000528283A JP 2002501021 A5 JP2002501021 A5 JP 2002501021A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- preparation according
- ropivacaine
- pain
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000825 pharmaceutical preparation Substances 0.000 description 8
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N Ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 description 6
- 229960001549 Ropivacaine Drugs 0.000 description 6
- 206010028391 Musculoskeletal pain Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 206010043255 Tendonitis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 150000004682 monohydrates Chemical group 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
Description
【特許請求の範囲】
【請求項１】 活性成分がロピバカインである、筋骨格疼痛の治療に筋肉内に使用する医薬製剤。
【請求項２】 筋骨格疼痛が筋膜疼痛である請求項１記載の医薬製剤。
【請求項３】 筋骨格疼痛が腱炎である請求項１記載の医薬製剤。
【請求項４】 ロピバカインがその一水和物形態である請求項１〜３のいずれか一項記載の医薬製剤。
【請求項５】 ロピバカインの濃度が１〜２０mg／mLである請求項１〜４のいずれか一項記載の医薬製剤。
【請求項６】 ロピバカインの濃度が１〜１０mg／mLである請求項５記載の医薬製剤。
【請求項７】 ロピバカインの濃度が２〜５mg／mLである請求項６記載の医薬製剤。
【請求項８】 ロピバカインの投与量が０.１〜１０mL／圧痛点または発痛点である請求項１〜７のいずれか一項記載の医薬製剤。
【請求項１】 活性成分がロピバカインである、筋骨格疼痛の治療に筋肉内に使用する医薬製剤。
【請求項２】 筋骨格疼痛が筋膜疼痛である請求項１記載の医薬製剤。
【請求項３】 筋骨格疼痛が腱炎である請求項１記載の医薬製剤。
【請求項４】 ロピバカインがその一水和物形態である請求項１〜３のいずれか一項記載の医薬製剤。
【請求項５】 ロピバカインの濃度が１〜２０mg／mLである請求項１〜４のいずれか一項記載の医薬製剤。
【請求項６】 ロピバカインの濃度が１〜１０mg／mLである請求項５記載の医薬製剤。
【請求項７】 ロピバカインの濃度が２〜５mg／mLである請求項６記載の医薬製剤。
【請求項８】 ロピバカインの投与量が０.１〜１０mL／圧痛点または発痛点である請求項１〜７のいずれか一項記載の医薬製剤。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800139A SE9800139D0 (sv) | 1998-01-21 | 1998-01-21 | New use |
| SE9800139-9 | 1998-01-21 | ||
| PCT/SE1999/000012 WO1999037301A1 (en) | 1998-01-21 | 1999-01-11 | New use for pain management |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002501021A JP2002501021A (ja) | 2002-01-15 |
| JP2002501021A5 true JP2002501021A5 (ja) | 2006-03-02 |
| JP4456754B2 JP4456754B2 (ja) | 2010-04-28 |
Family
ID=20409917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528283A Expired - Lifetime JP4456754B2 (ja) | 1998-01-21 | 1999-01-11 | 疼痛管理のための新規な使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6395291B1 (ja) |
| EP (1) | EP1054671B1 (ja) |
| JP (1) | JP4456754B2 (ja) |
| AT (1) | ATE228840T1 (ja) |
| AU (1) | AU2444399A (ja) |
| DE (1) | DE69904297T2 (ja) |
| DK (1) | DK1054671T3 (ja) |
| ES (1) | ES2189386T3 (ja) |
| PT (1) | PT1054671E (ja) |
| SE (1) | SE9800139D0 (ja) |
| WO (1) | WO1999037301A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200611217A (en) * | 2005-12-06 | 2006-04-01 | Shin Hwa Biotech Co Ltd | Human model for indexing nerve paths (locus) having corresponding relations and method for indexing |
| USRE46397E1 (en) | 2007-11-07 | 2017-05-09 | Svip5 Llc | Slow release of organic salts of local anesthetics for pain relief |
| US10111850B2 (en) * | 2015-12-01 | 2018-10-30 | Samuel Wilson | Ester and cholinesterase inhibitor in long-acting nerve block |
| CA2898933A1 (en) * | 2014-07-30 | 2016-01-30 | Grigory Karmy | Method for relieving chronic pain |
| US10751249B2 (en) * | 2017-11-26 | 2020-08-25 | Johnson Athletic Advantage LLC | Trigger point dry needling in motion and method of use |
| BE1026845B1 (nl) | 2018-12-07 | 2020-07-08 | Fagron Compounding Services Nv | Samenstelling voor gebruik in lokale infiltratie analgesie (LIA) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3379266D1 (en) | 1983-08-01 | 1989-04-06 | Astra Laekemedel Ab | L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same |
| SE451840B (sv) | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning |
| SE9401174D0 (sv) | 1994-04-07 | 1994-04-07 | Astra Ab | New combination |
| CA2285203C (en) | 1997-03-13 | 2005-07-26 | James N. Campbell | Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
-
1998
- 1998-01-21 SE SE9800139A patent/SE9800139D0/xx unknown
-
1999
- 1999-01-11 AU AU24443/99A patent/AU2444399A/en not_active Abandoned
- 1999-01-11 US US09/254,382 patent/US6395291B1/en not_active Expired - Lifetime
- 1999-01-11 WO PCT/SE1999/000012 patent/WO1999037301A1/en active IP Right Grant
- 1999-01-11 ES ES99903972T patent/ES2189386T3/es not_active Expired - Lifetime
- 1999-01-11 PT PT99903972T patent/PT1054671E/pt unknown
- 1999-01-11 JP JP2000528283A patent/JP4456754B2/ja not_active Expired - Lifetime
- 1999-01-11 AT AT99903972T patent/ATE228840T1/de active
- 1999-01-11 EP EP99903972A patent/EP1054671B1/en not_active Expired - Lifetime
- 1999-01-11 DK DK99903972T patent/DK1054671T3/da active
- 1999-01-11 DE DE69904297T patent/DE69904297T2/de not_active Expired - Lifetime
-
2002
- 2002-04-24 US US10/128,664 patent/US6620423B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
| BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| JP2005500357A5 (ja) | ||
| DK0503440T3 (da) | Sumatriptanholdige lægemidler | |
| DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| HUP0203733A2 (en) | Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy | |
| IT1276689B1 (it) | Forma farmaceutica solida ad uso orale | |
| MY130619A (en) | Pharmaceutical formulations of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene | |
| UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
| HK1071847A1 (en) | Dosage forms having prolonged active ingredient release | |
| WO2002030467A3 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| NO20023551D0 (no) | Ibuprofen-inneholdende aktivt middel-preparat | |
| JP2002522501A5 (ja) | ||
| SE0102440D0 (sv) | New compound | |
| JP2002537232A5 (ja) | ||
| JP2002501021A5 (ja) | ||
| JP2002542281A5 (ja) | ||
| WO2000048445A3 (de) | Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit | |
| JP2003522147A5 (ja) | ||
| JP2002537246A5 (ja) | ||
| JP2005513105A5 (ja) | ||
| IS6555A (is) | Meðferð með aðskildum skömmtum sem hafa æðaskaðandi virkni | |
| BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението |